Literature DB >> 23817797

Elucidating immune mechanisms causing hypertension during pregnancy.

Babbette LaMarca1, Denise Cornelius, Kedra Wallace.   

Abstract

Preeclampsia is associated with hypertension and increased infant and maternal morbidity and mortality. The underlying cause of preeclampsia is largely unknown, but it is clear that an immunological component plays a key pathophysiological role. This review will highlight immunological key players in the pathology of preeclampsia and discuss their role in the pathophysiology observed in the reduced placental perfusion (RUPP) rat model of preeclampsia.

Entities:  

Mesh：

Year:  2013        PMID： 23817797      PMCID： PMC3742131          DOI： 10.1152/physiol.00006.2013

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN： 1548-9221


  55 in total

1.  Maternal fetal/placental interactions and abnormal pregnancy outcomes.

Authors:  James M Roberts; Frauke Von Versen-Hoeynck
Journal:  Hypertension       Date:  2006-11-20       Impact factor: 10.190

2.  Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling.

Authors:  Roxanna A Irani; Yujin Zhang; Cissy Chenyi Zhou; Sean C Blackwell; M John Hicks; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2010-03-29       Impact factor: 10.190

3.  Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.

Authors:  Carl A Hubel; Gerd Wallukat; Myles Wolf; Florian Herse; Augustine Rajakumar; James M Roberts; Nina Markovic; Ravi Thadhani; Friedrich C Luft; Ralf Dechend
Journal:  Hypertension       Date:  2007-01-08       Impact factor: 10.190

Review 4.  Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension.

Authors:  Florian Herse; Babbette LaMarca
Journal:  Am J Reprod Immunol       Date:  2012-12-28       Impact factor: 3.886

5.  Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature.

Authors:  Thomas Walther; Gerd Wallukat; Alexander Jank; Sabine Bartel; Heinz-Peter Schultheiss; Renaldo Faber; Holger Stepan
Journal:  Hypertension       Date:  2005-10-31       Impact factor: 10.190

6.  Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation.

Authors:  Babbette Lamarca; Joshua Speed; Lillian Fournier Ray; Kathy Cockrell; Gerd Wallukat; Ralf Dechend; Joey Granger
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-11

7.  Functional changes of human peripheral B-lymphocytes in pre-eclampsia.

Authors:  Ai-Hua Liao; Li-Ping Liu; Wen-Ping Ding; Ling Zhang
Journal:  Am J Reprod Immunol       Date:  2009-05       Impact factor: 3.886

Review 8.  Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia.

Authors:  R N Taylor; C J de Groot; Y K Cho; K H Lim
Journal:  Semin Reprod Endocrinol       Date:  1998

9.  Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.

Authors:  Brigitte Santner-Nanan; Michael John Peek; Roma Khanam; Luise Richarts; Erhua Zhu; Barbara Fazekas de St Groth; Ralph Nanan
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

Review 10.  Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin?

Authors:  Babbette D LaMarca; Barbara T Alexander; Jeffery S Gilbert; Michael J Ryan; Mona Sedeek; Sydney R Murphy; Joey P Granger
Journal:  Gend Med       Date:  2008
View more
  36 in total

1.  Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats.

Authors:  Kathryn E Lillegard; Alex C Loeks-Johnson; Jonathan W Opacich; Jenna M Peterson; Ashley J Bauer; Barbara J Elmquist; Ronald R Regal; Jeffrey S Gilbert; Jean F Regal
Journal:  J Pharmacol Exp Ther       Date:  2014-08-22       Impact factor: 4.030

Review 2.  Fetal programming and cardiovascular pathology.

Authors:  Barbara T Alexander; John Henry Dasinger; Suttira Intapad
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

3.  CD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemia.

Authors:  Kedra Wallace; Denise C Cornelius; Jeremy Scott; Judith Heath; Janae Moseley; Krystal Chatman; Babbette LaMarca
Journal:  Hypertension       Date:  2014-08-04       Impact factor: 10.190

4.  An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia.

Authors:  Denise C Cornelius; Lorena M Amaral; Ashlyn Harmon; Kedra Wallace; Alexia J Thomas; Nathan Campbell; Jeremy Scott; Florian Herse; Nadine Haase; Janae Moseley; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

Review 5.  Inflammatory mediators: a causal link to hypertension during preeclampsia.

Authors:  Denise C Cornelius; Jesse Cottrell; Lorena M Amaral; Babbette LaMarca
Journal:  Br J Pharmacol       Date:  2018-09-28       Impact factor: 8.739

6.  Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.

Authors:  Jean F Regal; Megan E Strehlke; Jenna M Peterson; Cameron R Wing; Jordan E Parker; Noel Fernando Nieto; Lynne T Bemis; Jeffrey S Gilbert; Sherry D Fleming
Journal:  Mol Immunol       Date:  2016-08-30       Impact factor: 4.407

7.  Selective inhibition of 20-hydroxyeicosatetraenoic acid lowers blood pressure in a rat model of preeclampsia.

Authors:  Jessica L Faulkner; Nicole L Plenty; Kedra Wallace; Lorena M Amaral; Mark W Cunningham; Sydney Murphy; Babbette LaMarca
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-09-22       Impact factor: 3.072

Review 8.  Sex differences in stroke across the lifespan: The role of T lymphocytes.

Authors:  Javiera Bravo-Alegria; Louise D McCullough; Fudong Liu
Journal:  Neurochem Int       Date:  2017-01-25       Impact factor: 3.921

9.  Elevated vasopressin in pregnant mice induces T-helper subset alterations consistent with human preeclampsia.

Authors:  Sabrina M Scroggins; Donna A Santillan; Jenna M Lund; Jeremy A Sandgren; Lindsay K Krotz; Wendy S Hamilton; Eric J Devor; Heather A Davis; Gary L Pierce; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe; Mark K Santillan
Journal:  Clin Sci (Lond)       Date:  2018-02-14       Impact factor: 6.124

Review 10.  Identifying immune mechanisms mediating the hypertension during preeclampsia.

Authors:  Babbette LaMarca; Denise C Cornelius; Ashlyn C Harmon; Lorena M Amaral; Mark W Cunningham; Jessica L Faulkner; Kedra Wallace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-20       Impact factor: 3.619
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.